AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2023
Feb 22, 2023
29755_dirs_2023-02-21_47513114-f0c0-495d-9ba1-246e17f7568c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2023-02-17
Reporting Person: AUSTIN ROXANNE S (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-17 | Common Stock, $0.01 par value | S | 10000 | $150.50 | Disposed | 40705 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4